MENU
+Compare
MTNB
Stock ticker: ASE
AS OF
Apr 24, 04:51 PM (EDT)
Price
$0.59
Change
+$0.01 (+1.72%)
Capitalization
3.03M

MTNB Matinas Biopharma Holdings Inc Forecast, Technical & Fundamental Analysis

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products... Show more

Industry: #Biotechnology
MTNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for MTNB with price predictions
Apr 23, 2025

Momentum Indicator for MTNB turns positive, indicating new upward trend

MTNB saw its Momentum Indicator move above the 0 level on April 14, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 94 similar instances where the indicator turned positive. In of the 94 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for MTNB just turned positive on April 14, 2025. Looking at past instances where MTNB's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

MTNB moved above its 50-day moving average on April 22, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where MTNB advanced for three days, in of 217 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MTNB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MTNB broke above its upper Bollinger Band on March 21, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.399) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (34.843) is also within normal values, averaging (252.992).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MTNB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MTNB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
MTNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MTNB is expected to report earnings to fall 98.49% to -2 cents per share on November 06

Matinas Biopharma Holdings Inc MTNB Stock Earnings Reports
Q3'24
Est.
$-0.03
Q4'24
Missed
by $1.63
Q2'24
Beat
by $0.01
Q1'24
Est.
$-0.03
Q4'23
Beat
by $0.01
The last earnings report on April 15 showed earnings per share of -165 cents, missing the estimate of -2 cents. With 19.57K shares outstanding, the current market capitalization sits at 3.03M.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1545 Route 206 South
Phone
+1 908 484-8805
Employees
32
Web
https://www.matinasbiopharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REVB2.930.07
+2.63%
Revelation Biosciences Inc
CMPR42.611.02
+2.45%
Cimpress plc
MTUS13.200.06
+0.46%
Metallus
WBX0.38N/A
N/A
Wallbox NV
TXRH161.84-1.57
-0.96%
Texas Roadhouse

MTNB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MTNB has been loosely correlated with EQ. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if MTNB jumps, then EQ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTNB
1D Price
Change %
MTNB100%
-2.48%
EQ - MTNB
38%
Loosely correlated
+0.02%
ABCZF - MTNB
37%
Loosely correlated
N/A
SPRC - MTNB
35%
Loosely correlated
+4.52%
AXON - MTNB
34%
Loosely correlated
+3.82%
VKTX - MTNB
32%
Poorly correlated
+1.22%
More